Research Article
Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema
Table 3
Recurrence and retreatment number and times.
| | Total | Retreatment | Avg. recurrence time | Second retreatment | Secondary recurrence | Avg. recurrence time 2 | Retreatment |
| Recurrence in 6 months | | | | | | | | Group 1 | 16 eyes | 8 (out of 16) | 21 ± 2.6 weeks | 8 eyes | 6 eyes | 25 ± 1.3 weeks | 2 eyes | Group 2 | 4 eyes | 2 eyes | 21 weeks | 1 eye | | | | Recurrence > 6 month | | | | | | | | | 6–12 months | | | | | | Group 1 | 20 eyes | | | | | | | Group 2 | 6 eyes | | | | | | | Recurrence > 6 month | | | | | | | | Group 1 | 20 | 9 | 24.2 ± 1.3 weeks | 9 eyes | 6 eyes | 26.4 ± 1.8 weeks | 3 eyes | Group 2 | 6 | 4 | 24.16 ± 1.83 weeks | 2 eyes | 2 eyes | 25.1 ± 1.3 weeks | 1 eye |
|
|